Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Burkitt Lymphoma × Capecitabine × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 65 Colorectal Neoplasms 39 Rectal Neoplasms 33 Stomach Neoplasms 32 Triple Negative Breast Neoplasms 24 Neoplasm Metastasis 19 Esophageal Neoplasms 15 Colonic Neoplasms 15 Neoplasms 13 Pancreatic Neoplasms 10 Nasopharyngeal Carcinoma 10 Cholangiocarcinoma 10 Adenocarcinoma 10 Biliary Tract Neoplasms 9 Adenocarcinoma Of Esophagus 9 Recurrence 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Locally Advanced Rectal Cancer 7 Brain Neoplasms 7 Anus Neoplasms 6 Neuroendocrine Tumors 5 Gallbladder Neoplasms 5 HER2-positive Breast Cancer 4 Gastrointestinal Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Colorectal Cancer Metastatic 4 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Pathologic Complete Response 3 Ovarian Neoplasms 3

Interventions

Cyclophosphamide 49 Vincristine 31 Prednisone 27 Methotrexate 26 blinatumomab 23 Cytarabine 23 Rituximab 21 Doxorubicin 20 Dexamethasone 20 Etoposide 17 prednylidene 16 merphos 16 deltacortene 16 Mercaptopurine 16 fludarabine 15 Specimen Handling 15 Calcium Dobesilate 14 venetoclax 13 Inotuzumab Ozogamicin 13 CT-P10 13 Biopsy 13 dexamethasone acetate 12 dexamethasone 21-phosphate 12 azathiopurine 12 auricularum 12 fludarabine phosphate 11 N,N-dicyclohexyl-isoborneol-10-sulfonamide 11 Leucovorin 11 pegaspargase 10 Spinal Puncture 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡